5 authorised products containing Eribulin mesylate, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Eribulin Advanz Pharma 0.44 mg/ml solution for injection PA23450/001/001 |
Eribulin mesylate | Advanz Pharma Limited | Not marketed |
| Eribulin Baxter 0.44 mg/mL solution for injection EU/1/24/1819/001 |
Eribulin mesylate | Baxter Holding B.V. | — |
| Eribulin Tillomed 0.44 mg/ml solution for injection PA25239/001/001 |
Eribulin mesylate | Tillomed Malta Limited | Not marketed |
| HALAVEN 0.44 mg/ml solution for injection EU/1/11/678/001-002 |
Eribulin mesylate | Eisai GmbH | — |
| Mevlyq 0.44 mg/mL solution for injection EU/1/23/1789/001 |
Eribulin mesylate | Yes Pharmaceutical Development Services GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.